PSMD11
Gene Information
- Official Symbol: PSMD11
- Official Name: proteasome 26S subunit, non-ATPase 11
- Aliases and Previous Symbols: N/A
- Entrez ID: 5717
- UniProt: O00231
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. In the complex, PSMD11 is required for proteasome assembly. Plays a key role in increased proteasome activity in embryonic stem cells (ESCs): its high expression in ESCs promotes enhanced assembly of the 26S proteasome, followed by higher proteasome activity. {ECO:0000269|PubMed:1317798, ECO:0000269|PubMed:22972301}.
Pfam Domains GO Terms
Pfam Domains
| PCI |
GO Terms
| proteasome regulatory particle, lid subcomplex |
| proteasome assembly |
| proteasome accessory complex |
| proteasome complex |
| regulation of cellular amino acid metabolic process |
| regulation of hematopoietic stem cell differentiation |
| antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
| regulation of transcription from RNA polymerase II promoter in response to hypoxia |
| antigen processing and presentation of exogenous peptide antigen via MHC class I |
| NIK/NF-kappaB signaling |
| regulation of cellular amine metabolic process |
| anaphase-promoting complex-dependent catabolic process |
| regulation of hematopoietic progenitor cell differentiation |
| negative regulation of G2/M transition of mitotic cell cycle |
| SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
| interleukin-1-mediated signaling pathway |
| Wnt signaling pathway, planar cell polarity pathway |
| antigen processing and presentation of peptide antigen via MHC class I |
| negative regulation of cell cycle G2/M phase transition |
| regulation of establishment of planar polarity |
| stimulatory C-type lectin receptor signaling pathway |
| secretory granule lumen |
| innate immune response activating cell surface receptor signaling pathway |
| regulation of stem cell differentiation |
| tumor necrosis factor-mediated signaling pathway |
| regulation of transcription from RNA polymerase II promoter in response to stress |
| ficolin-1-rich granule lumen |
| regulation of DNA-templated transcription in response to stress |
| non-canonical Wnt signaling pathway |
| positive regulation of canonical Wnt signaling pathway |
| stem cell differentiation |
| regulation of cellular ketone metabolic process |
| Fc-epsilon receptor signaling pathway |
| cellular response to interleukin-1 |
| negative regulation of canonical Wnt signaling pathway |
| T cell receptor signaling pathway |
| antigen processing and presentation of exogenous peptide antigen |
| positive regulation of Wnt signaling pathway |
| regulation of mRNA stability |
| regulation of morphogenesis of an epithelium |
| antigen processing and presentation of exogenous antigen |
| regulation of RNA stability |
| cellular response to hypoxia |
| antigen processing and presentation of peptide antigen |
| structural molecule activity |
| regulation of G2/M transition of mitotic cell cycle |
| cellular response to decreased oxygen levels |
| response to interleukin-1 |
| regulation of mRNA catabolic process |
| negative regulation of Wnt signaling pathway |
| regulation of cell cycle G2/M phase transition |
| negative regulation of mitotic cell cycle phase transition |
| cellular response to oxygen levels |
| antigen processing and presentation |
| negative regulation of cell cycle phase transition |
| innate immune response-activating signal transduction |
| cellular response to tumor necrosis factor |
| Fc receptor signaling pathway |
| regulation of animal organ morphogenesis |
| activation of innate immune response |
| response to tumor necrosis factor |
| protein deubiquitination |
| regulation of canonical Wnt signaling pathway |
| antigen receptor-mediated signaling pathway |
| protein modification by small protein removal |
| protein polyubiquitination |
| negative regulation of mitotic cell cycle |
| proteasome-mediated ubiquitin-dependent protein catabolic process |
| negative regulation of cell cycle process |
| regulation of mRNA metabolic process |
| positive regulation of innate immune response |
| response to hypoxia |
| proteasomal protein catabolic process |
| Wnt signaling pathway |
| cell-cell signaling by wnt |
| response to decreased oxygen levels |
| regulation of Wnt signaling pathway |
| post-translational protein modification |
| positive regulation of response to biotic stimulus |
| MAPK cascade |
| response to oxygen levels |
| signal transduction by protein phosphorylation |
| regulation of mitotic cell cycle phase transition |
| cell surface receptor signaling pathway involved in cell-cell signaling |
| regulation of small molecule metabolic process |
| regulation of cell cycle phase transition |
| immune response-activating cell surface receptor signaling pathway |
| regulation of hemopoiesis |
| regulation of innate immune response |
| positive regulation of defense response |
| immune response-regulating cell surface receptor signaling pathway |
| neutrophil degranulation |
| neutrophil activation involved in immune response |
| neutrophil mediated immunity |
| neutrophil activation |
| granulocyte activation |
| positive regulation of multi-organism process |
| leukocyte degranulation |
| myeloid leukocyte mediated immunity |
| myeloid cell activation involved in immune response |
| regulation of response to biotic stimulus |
| posttranscriptional regulation of gene expression |
| ubiquitin-dependent protein catabolic process |
| modification-dependent protein catabolic process |
| modification-dependent macromolecule catabolic process |
| immune response-activating signal transduction |
| negative regulation of cell cycle |
| myeloid leukocyte activation |
| proteolysis involved in cellular protein catabolic process |
| immune response-regulating signaling pathway |
| positive regulation of response to external stimulus |
| cellular protein catabolic process |
| leukocyte activation involved in immune response |
| cell activation involved in immune response |
| activation of immune response |
| regulation of mitotic cell cycle |
| cytokine-mediated signaling pathway |
| protein catabolic process |
| protein ubiquitination |
| regulated exocytosis |
| regulation of cell cycle process |
| regulation of defense response |
| leukocyte mediated immunity |
| protein modification by small protein conjugation |
| regulation of multi-organism process |
| exocytosis |
| regulation of cellular catabolic process |
| cellular protein-containing complex assembly |
| positive regulation of immune response |
| cellular macromolecule catabolic process |
| leukocyte activation |
| protein phosphorylation |
| protein modification by small protein conjugation or removal |
| regulation of catabolic process |
| secretion by cell |
| cellular response to cytokine stimulus |
| export from cell |
| macromolecule catabolic process |
| organonitrogen compound catabolic process |
| regulation of anatomical structure morphogenesis |
| cell activation |
| immune effector process |
| regulation of response to external stimulus |
| response to cytokine |
| cell-cell signaling |
| secretion |
| regulation of immune response |
| positive regulation of immune system process |
| response to abiotic stimulus |
| regulation of cell cycle |
| negative regulation of signal transduction |
| proteolysis |
| transmembrane transport |
| phosphorylation |
| negative regulation of cell communication |
| negative regulation of signaling |
| regulation of response to stress |
| protein-containing complex assembly |
| negative regulation of response to stimulus |
| positive regulation of signal transduction |
| regulation of immune system process |
| intracellular signal transduction |
| cellular response to stress |
| organic substance catabolic process |
| cellular catabolic process |
| regulation of cell differentiation |
| positive regulation of cell communication |
| positive regulation of signaling |
| protein-containing complex subunit organization |
| immune response |
| extracellular region |
| vesicle-mediated transport |
| membrane |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| DDTL | 0.609 |
| PSMD1 | 0.573 |
| CHD4 | 0.565 |
| PAN2 | 0.564 |
| SMG1 | 0.559 |
| VASN | 0.559 |
| MT1E | 0.552 |
| PSMA6 | 0.55 |
| PAN3 | 0.548 |
| ZFAND5 | 0.548 |
| RPS28 | 0.545 |
| PSMD3 | 0.538 |
| PSMC6 | 0.535 |
| PSMC1 | 0.534 |
| LRR1 | 0.525 |
| TERF2 | 0.524 |
| TCEB3CL2 | 0.524 |
| CDC73 | 0.524 |
| PSMD13 | 0.523 |
| SCAF1 | 0.519 |
| PSMD14 | 0.519 |
| COPA | 0.519 |
| C14orf93 | 0.518 |
| SMG7 | 0.518 |
| ATXN1 | 0.516 |
| MYO1H | 0.515 |
| BCL2L1 | 0.511 |
| PSMB4 | 0.508 |
| COPE | 0.508 |
| RPS12 | 0.508 |
| COPG1 | 0.506 |
| KPNB1 | 0.505 |
| RFC1 | 0.504 |
| UBAP1 | 0.502 |
| CCNA2 | 0.501 |
| TCEB3C | 0.499 |
| TOP1MT | 0.497 |
| AAMP | 0.496 |
| TBC1D3G | 0.496 |
| NOP16 | 0.492 |
| ZNF106 | 0.49 |
| PSMC2 | 0.489 |
| POLA2 | 0.489 |
| DDT | 0.488 |
| RANBP2 | 0.487 |
| GID4 | 0.485 |
| TBC1D3H | 0.484 |
| TWISTNB | 0.484 |
| MYB | 0.482 |
| NPIPB5 | 0.48 |
| HAP1 | 0.479 |
| SSH2 | 0.479 |
| RBM39 | 0.477 |
| WDR43 | 0.476 |
| POLE | 0.476 |
| PSMB2 | 0.474 |
| KCTD17 | 0.474 |
| PSMA7 | 0.474 |
| C1QTNF9B | 0.474 |
| ORC1 | 0.473 |
| DTL | 0.473 |
| SUPT6H | 0.472 |
| ATP13A1 | 0.471 |
| ZNF830 | 0.471 |
| ISCU | 0.471 |
| RPS14 | 0.47 |
| TCEB3CL | 0.47 |
| PCF11 | 0.467 |
| CDT1 | 0.466 |
| ADRM1 | 0.466 |
| CBWD3 | 0.464 |
| RPS19 | 0.464 |
| RPSA | 0.464 |
| NUPL1 | 0.463 |
| OR10G3 | 0.463 |
| POLR2F | 0.463 |
| ORC6 | 0.462 |
| PWP2 | 0.462 |
| CASC3 | 0.46 |
| TBC1D3F | 0.46 |
| PSMB1 | 0.46 |
| CBWD5 | 0.459 |
| COL2A1 | 0.459 |
| PSMD7 | 0.459 |
| TFIP11 | 0.458 |
| NAPA | 0.457 |
| SFPQ | 0.456 |
| GOLGA8O | 0.456 |
| AHCTF1 | 0.456 |
| NBPF10 | 0.456 |
| DDX56 | 0.455 |
| RBBP5 | 0.454 |
| NOL10 | 0.454 |
| PSMC4 | 0.453 |
| TBC1D3E | 0.453 |
| CGB2 | 0.453 |
| TBC1D3I | 0.453 |
| TBC1D3K | 0.452 |
| CCDC94 | 0.452 |
| TBC1D3L | 0.452 |
| PLCG2 | 0.452 |
| MED12 | 0.451 |
| SYT9 | 0.45 |
| PLK4 | 0.448 |
| PSMC3 | 0.448 |
| RPL35 | 0.448 |
| PAF1 | 0.448 |
| RPS2 | 0.446 |
| AKIRIN2 | 0.446 |
| SF3A1 | 0.446 |
| UPF1 | 0.446 |
| DNM2 | 0.446 |
| CCDC64B | 0.446 |
| ABT1 | 0.446 |
| COPB2 | 0.445 |
| DISP2 | 0.445 |
| XYLT2 | 0.443 |
| CDCA3 | 0.442 |
| RRN3 | 0.442 |
| AQR | 0.442 |
| FAM160A1 | 0.441 |
| RAD21 | 0.441 |
| NBPF16 | 0.441 |
| PSMD6 | 0.44 |
| TSG101 | 0.439 |
| CACNA1A | 0.439 |
| GGA3 | 0.439 |
| RPS3A | 0.439 |
| ANKLE2 | 0.438 |
| HIST1H2BE | 0.438 |
| PDCD11 | 0.438 |
| CBWD6 | 0.437 |
| TBC1D3 | 0.437 |
| PSMC5 | 0.436 |
| SNRPA1 | 0.435 |
| NUP93 | 0.435 |
| DNTTIP2 | 0.435 |
| PRKCZ | 0.434 |
| MYH7B | 0.434 |
| DHX38 | 0.433 |
| PSMD2 | 0.432 |
| POLA1 | 0.432 |
| NUP54 | 0.432 |
| CTR9 | 0.432 |
| TRAIP | 0.431 |
| SF3A3 | 0.431 |
| XPO1 | 0.431 |
| TTYH1 | 0.43 |
| TERF1 | 0.43 |
| UTP3 | 0.43 |
| BRD2 | 0.43 |
| CHMP2A | 0.429 |
| NUP160 | 0.429 |
| SULT1A4 | 0.429 |
| SULT1A3 | 0.428 |
| RPS7 | 0.428 |
| CWC22 | 0.427 |
| CDC45 | 0.427 |
| UTP20 | 0.426 |
| RRP15 | 0.426 |
| OGFR | 0.426 |
| HIST2H2BF | 0.426 |
| TRA2B | 0.426 |
| NUP133 | 0.426 |
| RPL30 | 0.425 |
| NFE2L1 | 0.425 |
| TBC1D3C | 0.424 |
| TOPBP1 | 0.423 |
| KIF3C | 0.421 |
| MED14 | 0.42 |
| CHCHD3 | 0.42 |
| RFPL3 | 0.419 |
| USP36 | 0.419 |
| RPL14 | 0.418 |
| BYSL | 0.418 |
| TICRR | 0.418 |
| CMYA5 | 0.417 |
| SLC6A17 | 0.417 |
| TGM5 | 0.417 |
| NDC1 | 0.415 |
| RPL8 | 0.415 |
| SLC38A7 | 0.415 |
| AATF | 0.414 |
| NOL8 | 0.414 |
| LAD1 | 0.414 |
| BRIX1 | 0.414 |
| MDM2 | 0.413 |
| DOCK6 | 0.412 |
| SNIP1 | 0.411 |
| RPS9 | 0.41 |
| PLA2G4F | 0.409 |
| WDR87 | 0.409 |
| GAR1 | 0.409 |
| SSRP1 | 0.409 |
| GPRIN2 | 0.408 |
| ACSF2 | 0.408 |
| EXOSC5 | 0.407 |
| ZFYVE16 | 0.407 |
| SLC4A1 | 0.407 |
| ACBD4 | 0.407 |
| ANKLE1 | 0.406 |
| RNF121 | 0.406 |
| IGFN1 | 0.406 |
| S1PR4 | 0.405 |
| KLHL1 | 0.405 |
| KRT36 | 0.405 |
| EXOSC9 | 0.404 |
| IK | 0.404 |
| GOLGA6L3 | 0.404 |
| MYT1L | 0.404 |
| NOP14 | 0.404 |
| MYO18A | 0.403 |
| LIPE | 0.401 |
| DDX21 | 0.401 |
| TRIM52 | 0.401 |
| WDR75 | 0.401 |
| CHAF1A | 0.4 |
| PSMD12 | 0.4 |
| KRT78 | 0.4 |
| CLPTM1 | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 533/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 1/1 |
| bile duct | 20/28 |
| blood | 22/28 |
| bone | 18/26 |
| breast | 28/33 |
| central nervous system | 37/56 |
| cervix | 2/4 |
| colorectal | 8/17 |
| esophagus | 6/13 |
| fibroblast | 1/1 |
| gastric | 12/16 |
| kidney | 16/21 |
| liver | 16/20 |
| lung | 51/75 |
| lymphocyte | 14/16 |
| ovary | 22/26 |
| pancreas | 15/24 |
| peripheral nervous system | 13/16 |
| plasma cell | 14/15 |
| prostate | 0/1 |
| skin | 17/24 |
| soft tissue | 7/9 |
| thyroid | 2/2 |
| upper aerodigestive | 10/22 |
| urinary tract | 20/29 |
| uterus | 4/5 |
Essentiality in NALM6
- Essentiality Rank: 243
- Expression level (log2 read counts): 6.65
Expression Distribution
PSMD11 Expression in NALM6 Cells: 6.65
